Background: Previously, we reported that Inauhzin (INZ) induces p53 activity and suppresses tumor growth by inhibiting Sirt1. However, it remains unknown whether INZ may globally affect p53-dependent gene expression or not. Herein, we have conducted microarray and real-time PCR analyses of gene expression to determine the global effect of INZ on human p53-responsive transcriptome.
Methodology/principal Findings: In this study, we conducted microarray analysis followed by PCR validation of general gene expression in HCT116(p53+/+) and HCT116(p53-/-) cells treated with or without INZ. Microarray data showed that 324 genes were up-regulated by ≥ 2.3-fold and 266 genes were down-regulated by ≥ 2-fold in response to INZ treatment in a p53-dependent manner. GO analysis for these genes further revealed that INZ affects several biological processes, including apoptosis (GO:0006915), cell cycle (GO:0007049), immune system process (GO:0002376), and cell adhesion (GO:0007155), which are in line with p53 functions in cells. Also, pathway and STRING analyses of these genes indicated that the p53-signaling pathway is the most significant pathway responsive to INZ treatment as predicted, since a number of these p53 target genes have been previously reported and some of them were validated by RT-qPCR. Finally, among the 9 tested and highly expressed genes, ACBD4, APOBEC3C, and FLJ14327 could be novel p53 target genes, for they were up-regulated by INZ in HCT116(p53+/+) cells, but not in HCT116(p53-/-) cells.
Conclusions/significance: From our whole genome microarray analysis followed by validation with RT-qPCR, we found that INZ can indeed induce the expression of p53 target genes at a larger scale or globally. Our findings not only verify that INZ indeed activates the p53 signaling pathway, but also provide useful information for identifying novel INZ and/or p53 targets. The global effect of INZ on human p53-responsive transcriptome could also be instrumental to the future design of INZ clinical trials.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528779 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0052172 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Solution-mediated phase transformation of cocrystals at the solid-liquid interface: Relationships between the supersaturation generation rate and transformation pathway.
Int J Pharm
January 2025
State Key Laboratory of Natural Medicines, Department of Pharmaceutics, Department of Pharmaceutical Engineering, China Pharmaceutical University, Nanjing 211198, China. Electronic address:
Cocrystals easily undergo solution-mediated phase transformation at the surface of dissolving cocrystals during dissolution, which significantly deteriorates the solubility advantage of cocrystals. Here, a new scenario for the phase transformation of liquiritigenin (LQ) cocrystals in which the boundary of phase transformation diffuses along the surface to the bulk of the cocrystal was identified. Additionally, depending on the rate of supersaturation generation, phase transformation processes to the anhydrate and hydrate of LQ compete during cocrystal dissolution.
View Article and Find Full Text PDFNovel treatment for PXE: Recombinant ENPP1 enzyme therapy.
Mol Ther
November 2024
Department of Biochemistry and Molecular Biology, Sidney Kimmel Medical College, Jefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia, PA, USA; PXE International Center of Excellence in Research and Clinical Care, Thomas Jefferson University, Philadelphia, PA, USA. Electronic address:
Article Synopsis
- Pseudoxanthoma elasticum (PXE) is a genetic disorder caused by mutations in the ABCC6 gene, leading to impaired levels of a calcification inhibitor, plasma inorganic pyrophosphate (PPi).
- Recent studies show that a treatment called INZ-701 can restore PPi levels and prevent calcification in animal models, while the new enzyme therapy BL-1118 demonstrates effective results in increasing PPi levels and reducing ectopic calcification in mice.
- BL-1118's potential as a second-generation treatment suggests it may provide better efficacy than the ongoing first-generation therapies, with promising results from pharmacokinetic and pharmacodynamic studies.
Development of isoniazid electrochemical sensor using nickel ferrite - nitrogen and sulfur co-doped graphene quantum dot nanocomposite as a new electrode modifier.
Sci Rep
June 2024
Department of Physical Chemistry, Faculty of Chemistry, University of Tabriz, Tabriz, Iran.
This work reports the synthesis of nickel ferrite decorated nitrogen and sulfur co-doped graphene quantum dot (NF@N, S:GQD) and its use as an electrode modifier. The developed NF@N, S:GQD modified glassy carbon electrode (NF@N, S:GQD/GCE) was applied to assess isoniazid (INZ) concentration based on its oxidation at the surface of the proposed electrode. Cyclic voltammetry (CV) and differential pulse voltammetry (DPV) were used as appropriate electrochemical techniques to study the electrochemical behavior of INZ and determine it.
View Article and Find Full Text PDFTreatment of ear trauma within the Ukrainian military: organisational requirements and implementation of a three-stage regimen.
BMJ Mil Health
May 2024
Department of Teleaudiology and Screening, Institute for Pathology and Physiology of Hearing, Warszawa, Poland
Evaluation of Prehospital Undertriage in Relation to Trauma Team Activation-Results from a Prospective Study in 12 Level one German Trauma Centers.
J Clin Med
March 2024
Department of Trauma Surgery and Orthopaedic Surgery, Berufsgenossenschaftliche Unfallklinik Frankfurt, 60389 Frankfurt am Main, Germany.
This prospective, multicenter observational cohort study was carried out in 12 trauma centers in Germany and Switzerland. Its purpose was to evaluate the rate of undertriage, as well as potential consequences, and relate these with different Trauma Team Activation Protocols (TTA-Protocols), as this has not been done before in Germany. : Each trauma center collected the data during a three-month period between December 2019 and February 2021.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!